Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.
about
Evaluation of Protein Profiles From Treated Xenograft Tumor Models Identifies an Antibody Panel for Formalin-fixed and Paraffin-embedded (FFPE) Tissue Analysis by Reverse Phase Protein Arrays (RPPA)Evanescent wave fluorescence biosensors: Advances of the last decadeTumor size and proliferative marker geminin rather than Ki67 expression levels significantly associated with maximum uptake of 18F-deoxyglucose levels on positron emission tomography for breast cancers.
P2860
Evaluation of efficacy of a new MEK inhibitor, RO4987655, in human tumor xenografts by [(18)F] FDG-PET imaging combined with proteomic approaches.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
2014年论文
@zh
2014年论文
@zh-cn
name
Evaluation of efficacy of a ne ...... ned with proteomic approaches.
@ast
Evaluation of efficacy of a ne ...... ned with proteomic approaches.
@en
type
label
Evaluation of efficacy of a ne ...... ned with proteomic approaches.
@ast
Evaluation of efficacy of a ne ...... ned with proteomic approaches.
@en
prefLabel
Evaluation of efficacy of a ne ...... ned with proteomic approaches.
@ast
Evaluation of efficacy of a ne ...... ned with proteomic approaches.
@en
P2093
P2860
P1433
P1476
Evaluation of efficacy of a ne ...... ined with proteomic approaches
@en
P2093
Elisabeth Ruge
Jan Mulder
Jean Tessier
Michael Pawlak
Miro Venturi
Nobuya Ishii
Sabine Bader
Satoshi Aida
Sharon Stone-Elander
P2860
P2888
P356
10.1186/S13550-014-0034-6
P577
2014-09-09T00:00:00Z
P5875
P6179
1008344295